Physician-Level Variation in Under-recognition of Angina
Patients with heart failure or less-frequent angina were most likely to have their condition under-recognized.
Patients with heart failure or less-frequent angina were most likely to have their condition under-recognized.
No reduction in cardiovascular morbidity or mortality at 30-day and 3-year follow-up.
Migraine prevalence was 60% in patients with cardiac syndrome X, 16% in patients with coronary artery disease, and 225 in the healthy control group.
Patients with severe aortic stenosis without coronary artery disease demonstrated reduced myocardial perfusion reserve.
In the RWISE study, ranolazine did not improve SAQ angina or myocardial perfusion index in patients with microvascular dysfunction.
Ranolazine did not benefit angina or quality of life in patients who had incomplete percutaneous coronary intervention revascularization.